Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Guminski AD"'
Publikováno v:
High Temperature Materials and Processes, Vol 38, Iss 2019, Pp 8-15 (2019)
The present research was aimed at determining the effects of the oxide layers on hydrogen absorption, microstructure and mechanical properties of the Zircaloy-2 and Zr 702 alloys. The oxidation was made at 350 °C, 700 °C and 900 °C for 10 to 30 mi
Externí odkaz:
https://doaj.org/article/ce2b1468598546ab8d2f7d67a0691873
Autor:
Guminski AD (AUTHOR), Harnett PR (AUTHOR), deFazio A (AUTHOR), Guminski, Alexander D1 (AUTHOR), Harnett, Paul R (AUTHOR), deFazio, Anna (AUTHOR)
Publikováno v:
Lancet Oncology. May2002, Vol. 3 Issue 5, p312-318. 7p.
Autor:
McLean LS; Peter MacCallum Cancer Centre, Melbourne, VIC.; The University of Melbourne, Melbourne, VIC., Lim AM; Peter MacCallum Cancer Centre, Melbourne, VIC.; The University of Melbourne, Melbourne, VIC., Bressel M; The University of Melbourne, Melbourne, VIC.; Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, VIC., Lee J; Chris O'Brien Lifehouse, Sydney, NSW.; Macquarie University, Sydney, NSW., Ladwa R; Princess Alexandra Hospital, Brisbane, QLD.; The University of Queensland, Brisbane, QLD., Guminski AD; Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, NSW., Hughes B; The University of Queensland, Brisbane, QLD.; Royal Brisbane and Women's Hospital, Brisbane, QLD., Bowyer S; Sir Charles Gairdner Hospital, Perth, WA., Briscoe K; Mid North Coast Cancer Institute, Coffs Harbour, NSW., Harris S; Bendigo Cancer Centre, Bendigo Health, Bendigo, VIC., Kukard C; Central Coast Cancer Centre, Gosford, NSW., Zielinski R; Central West Cancer Care Centre, Orange, NSW.; Western Sydney University, Penrith, NSW., Alamgeer M; Monash Health, Melbourne, VIC.; Monash University, Melbourne, VIC., Carlino M; Melanoma Institute Australia, Westmead and Blacktown Hospitals, Sydney, NSW.; The University of Sydney, Sydney, NSW., Mo J; Westmead Hospital, Sydney, NSW., Park JJ; Nepean Cancer Care Centre, Penrith, NSW., Khattak MA; Fiona Stanley Hospital, Perth, WA.; Edith Cowan University, Perth, WA., Day F; Calvary Mater Newcastle, Newcastle, NSW., Rischin D; Peter MacCallum Cancer Centre, Melbourne, VIC.; The University of Melbourne, Melbourne, VIC.
Publikováno v:
The Medical journal of Australia [Med J Aust] 2024 Feb 05; Vol. 220 (2), pp. 80-90. Date of Electronic Publication: 2024 Jan 11.
Autor:
Thompson JR; Melanoma Institute of Australia, The University of Sydney, Wollstonecraft, New South Wales, 2065, Australia., Lai-Kwon J; Department of Medical Oncology, Peter MacCallum Cancer Center, Melbourne, Victoria, 3000, Australia., Morton RL; Melanoma Institute of Australia, The University of Sydney, Wollstonecraft, New South Wales, 2065, Australia.; National Health and Medical Research Council Clinical Trials Center, Faculty of Medicine & Health, The University of Sydney, Sydney, New South Wales, 2050, Australia., Guminski AD; Melanoma Institute of Australia, The University of Sydney, Wollstonecraft, New South Wales, 2065, Australia.; Royal North Shore & Mater Hospitals, Sydney, New South Wales, 2065, Australia., Gonzalez M; Melanoma Institute of Australia, The University of Sydney, Wollstonecraft, New South Wales, 2065, Australia., Atkinson V; Princess Alexandra Hospital, Woolloongabba, Queensland, 4102, Australia.; Faculty of Medicine, University of Queensland, Brisbane, Queensland, 4072, Australia., Sandhu S; Department of Medical Oncology, Peter MacCallum Cancer Center, Melbourne, Victoria, 3000, Australia., Brown MP; Translational Oncology Laboratory, Center for Cancer Biology, SA Pathology & University of South Australia, Adelaide, South Australia, 5001, Australia.; Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, South Australia, 5000, Australia.; Adelaide Medical School, University of Adelaide, Adelaide, South Australia, 5005, Australia., Menzies AM; Melanoma Institute of Australia, The University of Sydney, Wollstonecraft, New South Wales, 2065, Australia.; Royal North Shore & Mater Hospitals, Sydney, New South Wales, 2065, Australia.; Faculty of Medicine & Health, The University of Sydney, Sydney, New South Wales, 2006, Australia., McArthur GA; Department of Medical Oncology, Peter MacCallum Cancer Center, Melbourne, Victoria, 3000, Australia., Lo SN; Melanoma Institute of Australia, The University of Sydney, Wollstonecraft, New South Wales, 2065, Australia.; Faculty of Medicine & Health, The University of Sydney, Sydney, New South Wales, 2006, Australia., Long GV; Melanoma Institute of Australia, The University of Sydney, Wollstonecraft, New South Wales, 2065, Australia.; Royal North Shore & Mater Hospitals, Sydney, New South Wales, 2065, Australia.; Faculty of Medicine & Health, The University of Sydney, Sydney, New South Wales, 2006, Australia.; Charles Perkins Center, The University of Sydney, Sydney, New South Wales, 2006, Australia., Bartula I; Melanoma Institute of Australia, The University of Sydney, Wollstonecraft, New South Wales, 2065, Australia.
Publikováno v:
Immunotherapy [Immunotherapy] 2023 Jun; Vol. 15 (8), pp. 593-610. Date of Electronic Publication: 2023 May 02.
Autor:
Vergara IA; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia; Charles Perkin Centre, The University of Sydney, Sydney, NSW, Australia., Aivazian K; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia., Carlino MS; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia; Department of Medicine, Blacktown Hospital, Blacktown, New South Wales, Australia; Department of Medicine, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia., Guminski AD; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia., Maher NG; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia., Shannon KF; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia; Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia., Ch'ng S; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia; Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia., Saw RPM; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia; Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia; Charles Perkin Centre, The University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia., Wilmott JS; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia; Charles Perkin Centre, The University of Sydney, Sydney, NSW, Australia., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia; Charles Perkin Centre, The University of Sydney, Sydney, NSW, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia. Electronic address: richard.scolyer@health.nsw.gov.au.
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2023 Apr; Vol. 36 (4), pp. 100099. Date of Electronic Publication: 2023 Jan 10.
Autor:
Rawson RV; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Departments of Tissue Pathology and Diagnostic Oncology, Sydney, Australia; Department of Melanoma Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia; NSW Health Pathology, Sydney, Australia., Adhikari C; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Departments of Tissue Pathology and Diagnostic Oncology, Sydney, Australia; Department of Melanoma Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia; NSW Health Pathology, Sydney, Australia., Bierman C; The Netherlands Cancer Institute, Amsterdam, The Netherlands., Lo SN; Melanoma Institute Australia, The University of Sydney, Sydney, Australia., Shklovskaya E; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia., Rozeman EA; The Netherlands Cancer Institute, Amsterdam, The Netherlands., Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal North Shore Hospital, Sydney, Australia; Mater Hospital, Sydney, Australia., van Akkooi ACJ; The Netherlands Cancer Institute, Amsterdam, The Netherlands., Shannon KF; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Departments of Tissue Pathology and Diagnostic Oncology, Sydney, Australia; Department of Melanoma Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia., Gonzalez M; Melanoma Institute Australia, The University of Sydney, Sydney, Australia., Guminski AD; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Royal North Shore Hospital, Sydney, Australia; Mater Hospital, Sydney, Australia., Tetzlaff MT; Department of Pathology, Dermatopathology and Oral Pathology Unit, The University of California, San Francisco, San Francisco, USA; Department of Dermatology, Dermatopathology and Oral Pathology Unit, The University of California, San Francisco, San Francisco, USA., Stretch JR; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Departments of Tissue Pathology and Diagnostic Oncology, Sydney, Australia; Department of Melanoma Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia; Mater Hospital, Sydney, Australia., Eriksson H; Theme Cancer, Skin Cancer Center/Department of Oncology, Karolinska University Hospital, Stockholm, Sweden; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., van Thienen JV; The Netherlands Cancer Institute, Amsterdam, The Netherlands., Wouters MW; The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands., Haanen JBAG; The Netherlands Cancer Institute, Amsterdam, The Netherlands., Klop WMC; The Netherlands Cancer Institute, Amsterdam, The Netherlands., Zuur CL; The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Houdt WJ; The Netherlands Cancer Institute, Amsterdam, The Netherlands., Nieweg OE; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Departments of Tissue Pathology and Diagnostic Oncology, Sydney, Australia; Department of Melanoma Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia; Mater Hospital, Sydney, Australia., Ch'ng S; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Departments of Tissue Pathology and Diagnostic Oncology, Sydney, Australia; Department of Melanoma Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia; Mater Hospital, Sydney, Australia., Rizos H; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia., Saw RPM; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Departments of Tissue Pathology and Diagnostic Oncology, Sydney, Australia; Department of Melanoma Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia; Mater Hospital, Sydney, Australia., Spillane AJ; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal North Shore Hospital, Sydney, Australia; Mater Hospital, Sydney, Australia., Wilmott JS; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia., Blank CU; The Netherlands Cancer Institute, Amsterdam, The Netherlands., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal North Shore Hospital, Sydney, Australia; Mater Hospital, Sydney, Australia., van de Wiel BA; The Netherlands Cancer Institute, Amsterdam, The Netherlands., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Departments of Tissue Pathology and Diagnostic Oncology, Sydney, Australia; Department of Melanoma Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia; NSW Health Pathology, Sydney, Australia. Electronic address: Richard.Scolyer@health.nsw.gov.au.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2021 Jun; Vol. 32 (6), pp. 766-777. Date of Electronic Publication: 2021 Mar 17.
Autor:
Carlino MS; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia. matteo.carlino@sydney.edu.au.; Department of Medicine, Blacktown Hospital, Blacktown, New South Wales, Australia.; Department of Medicine, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia., Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia., Atkinson V; Department of Medical Oncology, Gallipoli Medical Research Foundation, Greenslopes Private Hospital, University of Queensland, Greenslopes, Queensland, Australia., Cebon JS; Department of Hematology and Oncology, Olivia Newton John Cancer Research Institute, Heidelberg, Victoria, Australia.; School of Cancer Medicine, La Trobe University, Heidelberg, Victoria, Australia.; Department of Medical Oncology, Austin Health, Heidelberg, Victoria, Australia., Jameson MB; Regional Cancer Centre, Waikato Hospital, and Waikato Clinical Campus, University of Auckland, Hamilton, New Zealand., Fitzharris BM; Canterbury Regional Cancer & Haematology Service, Christchurch Hospital, Christchurch, New Zealand., McNeil CM; Department of Medical Oncology, Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia., Hill AG; Department of Medical Oncology, Tasman Health Care, Gold Coast University Hospital, Southport, Queensland, Australia., Ribas A; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California., Atkins MB; Department of Oncology, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC., Thompson JA; Department of Medicine, Seattle Cancer Care Alliance, University of Washington, Seattle, Washington., Hwu WJ; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Guminski AD; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia., Kefford R; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Department of Medicine, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia.; Department of Clinical Medicine, Macquarie University, Macquarie Park, New South Wales, Australia., Wu H; Department of Clinical Oncology, MSD China, Beijing, China., Ibrahim N; Department of Clinical Oncology, Merck & Co., Inc., Kenilworth, New Jersey., Homet Moreno B; Department of Clinical Oncology, Merck & Co., Inc., Kenilworth, New Jersey., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Oct 01; Vol. 26 (19), pp. 5086-5091. Date of Electronic Publication: 2020 Jun 30.
Autor:
Tsang VHM; Department of Diabetes, Endocrinology & Metabolism, Royal North Shore Hospital, St Leonards Sydney, Australia.; Sydney Medical School, Northern, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; Cancer Genetics Laboratory, Hormones and Cancer Group, Kolling Institute of Medical Research, Sydney, NSW, Australia., McGrath RT; Department of Diabetes, Endocrinology & Metabolism, Royal North Shore Hospital, St Leonards Sydney, Australia.; Sydney Medical School, Northern, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia., Clifton-Bligh RJ; Department of Diabetes, Endocrinology & Metabolism, Royal North Shore Hospital, St Leonards Sydney, Australia.; Sydney Medical School, Northern, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; Cancer Genetics Laboratory, Hormones and Cancer Group, Kolling Institute of Medical Research, Sydney, NSW, Australia., Scolyer RA; Melanoma Institute Australia and The University of Sydney, Sydney, Australia.; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia., Jakrot V; Melanoma Institute Australia and The University of Sydney, Sydney, Australia., Guminski AD; Melanoma Institute Australia and The University of Sydney, Sydney, Australia.; Departments of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, Australia., Long GV; Melanoma Institute Australia and The University of Sydney, Sydney, Australia.; Departments of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, Australia., Menzies AM; Melanoma Institute Australia and The University of Sydney, Sydney, Australia.; Departments of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, Australia.
Publikováno v:
The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2020 Jun 01; Vol. 105 (6).
Autor:
Tsang VHM; Department of Diabetes, Endocrinology & Metabolism and Northern Clinical School, the University of Sydney, Royal North Shore Hospital, St Leonards, New South Wales, Australia.; Cancer Genetics Laboratory, Hormones and Cancer Group, Kolling Institute of Medical Research, Sydney, New South Wales, Australia., McGrath RT; Department of Diabetes, Endocrinology & Metabolism and Northern Clinical School, the University of Sydney, Royal North Shore Hospital, St Leonards, New South Wales, Australia., Clifton-Bligh RJ; Department of Diabetes, Endocrinology & Metabolism and Northern Clinical School, the University of Sydney, Royal North Shore Hospital, St Leonards, New South Wales, Australia.; Cancer Genetics Laboratory, Hormones and Cancer Group, Kolling Institute of Medical Research, Sydney, New South Wales, Australia., Scolyer RA; Melanoma Institute Australia and the University of Sydney, Sydney, New South Wales, Australia.; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia., Jakrot V; Melanoma Institute Australia and the University of Sydney, Sydney, New South Wales, Australia., Guminski AD; Melanoma Institute Australia and the University of Sydney, Sydney, New South Wales, Australia.; Department of Medical Oncology, Royal North Shore Hospital, St Leonards, New South Wales, Australia.; Department of Medical Oncology, Mater Hospital, Sydney, New South Wales, Australia., Long GV; Melanoma Institute Australia and the University of Sydney, Sydney, New South Wales, Australia.; Department of Medical Oncology, Royal North Shore Hospital, St Leonards, New South Wales, Australia.; Department of Medical Oncology, Mater Hospital, Sydney, New South Wales, Australia., Menzies AM; Melanoma Institute Australia and the University of Sydney, Sydney, New South Wales, Australia.; Department of Medical Oncology, Royal North Shore Hospital, St Leonards, New South Wales, Australia.; Department of Medical Oncology, Mater Hospital, Sydney, New South Wales, Australia.
Publikováno v:
The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2019 Nov 01; Vol. 104 (11), pp. 5499-5506.
Autor:
Rozeman EA; The Netherlands Cancer Institute, Amsterdam, Netherlands., Menzies AM; Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia., van Akkooi ACJ; The Netherlands Cancer Institute, Amsterdam, Netherlands., Adhikari C; Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia., Bierman C; The Netherlands Cancer Institute, Amsterdam, Netherlands., van de Wiel BA; The Netherlands Cancer Institute, Amsterdam, Netherlands., Scolyer RA; Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Krijgsman O; The Netherlands Cancer Institute, Amsterdam, Netherlands., Sikorska K; The Netherlands Cancer Institute, Amsterdam, Netherlands., Eriksson H; Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden., Broeks A; The Netherlands Cancer Institute, Amsterdam, Netherlands., van Thienen JV; The Netherlands Cancer Institute, Amsterdam, Netherlands., Guminski AD; Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia., Acosta AT; The Netherlands Cancer Institute, Amsterdam, Netherlands., Ter Meulen S; The Netherlands Cancer Institute, Amsterdam, Netherlands., Koenen AM; The Netherlands Cancer Institute, Amsterdam, Netherlands., Bosch LJW; The Netherlands Cancer Institute, Amsterdam, Netherlands., Shannon K; Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Pronk LM; The Netherlands Cancer Institute, Amsterdam, Netherlands., Gonzalez M; Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia., Ch'ng S; Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Grijpink-Ongering LG; The Netherlands Cancer Institute, Amsterdam, Netherlands., Stretch J; Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Heijmink S; The Netherlands Cancer Institute, Amsterdam, Netherlands., van Tinteren H; The Netherlands Cancer Institute, Amsterdam, Netherlands., Haanen JBAG; The Netherlands Cancer Institute, Amsterdam, Netherlands., Nieweg OE; Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Klop WMC; The Netherlands Cancer Institute, Amsterdam, Netherlands., Zuur CL; The Netherlands Cancer Institute, Amsterdam, Netherlands., Saw RPM; Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia., van Houdt WJ; The Netherlands Cancer Institute, Amsterdam, Netherlands., Peeper DS; The Netherlands Cancer Institute, Amsterdam, Netherlands., Spillane AJ; Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia., Hansson J; Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden., Schumacher TN; The Netherlands Cancer Institute, Amsterdam, Netherlands., Long GV; Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia., Blank CU; The Netherlands Cancer Institute, Amsterdam, Netherlands. Electronic address: c.blank@nki.nl.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2019 Jul; Vol. 20 (7), pp. 948-960. Date of Electronic Publication: 2019 May 31.